Case Study of Pharmaceutical Companies Case Study

Management

Case Analysis: Pharma, Intellectual Property

Prior to 2003, the U.S. pharmaceutical industry heavily restricted intellectual property rights that would allow African countries and others ravaged by AIDS to receive generic medicine

There are a great deal of shocking statistics regarding the global populations living with and dying from AIDS, particularly in the age group of 15 -- 19

Health is a factors that is considered relative to a country's wealth; in Africa, a continent that is rich in natural resources, yet those resources are not controlled by the indigenous peoples, the number of people with AIDS is yet another way that Africa's extreme poverty demonstrates itself

Most of the people in the world who died from AIDS annually, are those from the southern parts of Africa

Pharmaceutical treatments are not cheap or instantaneous; the industry booms and will continue to do so for years to come because of the nature of the treatments and economies

Intellectual property rights and other forms of copyright are central to the control the pharmaceutical industry exudes over countries around the world who buy from them or are forced because of restrictions or poverty to resort to other options to acquire imported drugs of equal or lesser quality.

Pharmaceutical corporations continue to spend great sums upon marketing and publicity; they additionally continue to resist or otherwise criticize efforts to make drugs cheap, affordable, and/or free.

In the early 21st century, there were a number of initiatives started to combat AIDS and provide affordable treatment to the poorest countries, including the Global Fund.

2. Three main issues

AIDS…